- Home
- NUKK vs CTOR Comparison
NUKK vs CTOR Comparison
Compare NUKK & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUKK
- CTOR
- Stock Information
- Founded
- NUKK 2013
- CTOR 2021
- Country
- NUKK United States
- CTOR United States
- Employees
- NUKK N/A
- CTOR N/A
- Industry
- NUKK Blank Checks
- CTOR
- Sector
- NUKK Finance
- CTOR
- Exchange
- NUKK Nasdaq
- CTOR NYSE
- Market Cap
- NUKK 83.3M
- CTOR 89.9M
- IPO Year
- NUKK N/A
- CTOR N/A
- Fundamental
- Price
- NUKK $13.66
- CTOR $0.71
- Analyst Decision
- NUKK
- CTOR Strong Buy
- Analyst Count
- NUKK 0
- CTOR 2
- Target Price
- NUKK N/A
- CTOR $4.50
- AVG Volume (30 Days)
- NUKK 151.3K
- CTOR 3.9M
- Earning Date
- NUKK 05-15-2025
- CTOR 05-21-2025
- Dividend Yield
- NUKK N/A
- CTOR N/A
- EPS Growth
- NUKK N/A
- CTOR N/A
- EPS
- NUKK N/A
- CTOR N/A
- Revenue
- NUKK $5,913,461.00
- CTOR N/A
- Revenue This Year
- NUKK N/A
- CTOR N/A
- Revenue Next Year
- NUKK N/A
- CTOR N/A
- P/E Ratio
- NUKK N/A
- CTOR N/A
- Revenue Growth
- NUKK N/A
- CTOR N/A
- 52 Week Low
- NUKK $1.30
- CTOR $0.55
- 52 Week High
- NUKK $78.32
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- NUKK 45.02
- CTOR N/A
- Support Level
- NUKK $11.08
- CTOR N/A
- Resistance Level
- NUKK $19.79
- CTOR N/A
- Average True Range (ATR)
- NUKK 2.07
- CTOR 0.00
- MACD
- NUKK -0.04
- CTOR 0.00
- Stochastic Oscillator
- NUKK 29.63
- CTOR 0.00
About NUKK Nukkleus Inc.
Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.